Italia markets open in 2 hours 35 minutes

TEVA Jan 2025 21.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
4,45000,0000 (0,00%)
In data: 10:24AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente4,4500
Aperto4,4500
Denaro4,9000
Domanda5,0500
Prezzo d'esercizio21,00
Scadenza2025-01-17
Min-Max giorno4,4500 - 4,4500
Contratto - Min-MaxN/D
Volume22
Open Interest83
  • GlobeNewswire

    Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

    TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that they have agreed to expand their existing strategic partnership agreement.